In the spirit of helping pharmacists and retail healthcare teams lead by example, Drug Store News and higi have issued a call to entry for the next round of the Fit Pharmacist Challenge, which kicks off in October.
Perrigo received Food and Drug Administration approval for a therapeutic equivalent to Valeant’s BenzaClin acne treatment.
Impax Laboratories announced Tuesday that the Food and Drug Administration had approved its generic of Valeant’s Testred (methyltestosterone) capsules.
According to Protein Sciences, Flublok is the only flu vaccine that is free of formaldehyde, antibiotics, gluten, gelatin, egg protein, latex, thimerosal and other preservatives.
Keveyis was recently approved for the treatment of primary hyperkalemic and hypokalemic periodic paralysis, a group of rare hereditary disorders that cause episodes of muscle weakness or paralysis.
This is Impax’s first drug to be approved following its Sept. 4 resolution of issues outlined by the FDA in a warning letter to the company.
A new CVS Health Research Insitute study, done in partnership with Brigham and Women’s Hospital, is offering insight into the reasons many patients don’t adhere to their medication regimen.
For the U.S. pharmaceutical market, 2015 is already shaping up to be another double-digit growth year in terms of prescription spend, and brand-name specialty drugs are big drivers of that growth.
The Centers for Disease Control and prevention this week announced that a new draft guideline for prescribing opioids to patients with chronic pain was in the works.